Get the Stockscreener App
47.26
3.71%
1.69
After Hours:
47.16
-0.10
-0.21%
Proshares Ultra Nasdaq Biotechnology 2 X Shares stock is traded at $47.26, with a volume of 8,682.
It is up +3.71% in the last 24 hours and down -14.07% over the past month.
See More
Previous Close:
$45.57
Open:
$45.47
24h Volume:
8,682
Relative Volume:
1.00
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-6.66%
1M Performance:
-14.07%
6M Performance:
-25.25%
1Y Performance:
-13.06%
1-Day Range:
$45.47
$47.28
1-Week Range:
$45.46
$51.30
52-Week Range:
$45.46
$69.56
Proshares Ultra Nasdaq Biotechnology 2 X Shares Stock (BIB) Company Profile
Name
Proshares Ultra Nasdaq Biotechnology 2 X Shares
Sector
Industry
Phone
-
Address
-
Compare BIB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BIB
Proshares Ultra Nasdaq Biotechnology 2 X Shares
|
47.26 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
277.95 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
564.52 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
567.20 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
226.03 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
476.15 | 124.43B | 0 | 0 | 0 | 0.00 |
Proshares Ultra Nasdaq Biotechnology 2 X Shares Stock (BIB) Latest News
Best Stocks Under $20 Right Now - Benzinga
ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Sees Large Drop in Short Interest - MarketBeat
ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) to Issue $0.13 Quarterly Dividend - MarketBeat
Short Interest in Alpha Technology Group Limited (NASDAQ:ATGL) Decreases By 17.1% - Defense World
ProShares UltraShort QQQ (NYSEARCA:QID) Stock Cross Above 200-Day Moving Average – Here’s What Happened - Defense World
Short Interest in AlphaTime Acquisition Corp (NASDAQ:ATMC) Decreases By 12.5% - Defense World
B. Riley Forecasts Strong Price Appreciation for Rigel Pharmaceuticals (NASDAQ:RIGL) Stock - Defense World
Short Interest in Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Expands By 21.3% - Defense World
VirnetX (NYSE:VHC) Stock Price Crosses Above 200-Day Moving Average – Should You Sell? - Defense World
Cloud Peak Energy (OTCMKTS:CLDPQ) Stock Price Passes Above 200 Day Moving Average – Time to Sell? - Defense World
MicroVision (NASDAQ:MVIS) Shares Pass Above 200 Day Moving Average – Here’s What Happened - Defense World
Pacific Drilling (OTCMKTS:PACDQ) Shares Pass Above 200 Day Moving Average – What’s Next? - Defense World
Helpport AI (NASDAQ:HPAI) Trading Down 4.8% – Here’s Why - Defense World
BranchOut Food Inc. (NASDAQ:BOF) Sees Large Increase in Short Interest - Defense World
Short Interest in Better Home & Finance Holding (NASDAQ:BETR) Declines By 12.5% - Defense World
Private Advisor Group LLC Sells 11,056 Shares of First Bank (NASDAQ:FRBA) - Defense World
Saratoga Resources (OTCMKTS:SARA) Share Price Crosses Above 200-Day Moving Average – Here’s What Happened - Defense World
Hull Tactical US ETF (NYSEARCA:HTUS) Shares Sold by Private Advisor Group LLC - Defense World
BriaCell Therapeutics Corp. (NASDAQ:BCTXW) Short Interest Update - Defense World
Private Advisor Group LLC Grows Stock Holdings in JPMorgan BetaBuilders U.S. Aggregate Bond ETF (NYSEARCA:BBAG) - Defense World
ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) Short Interest Update - Defense World
Short Interest in ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Grows By 154.5% - Defense World
Global X Blockchain & Bitcoin Strategy ETF (NASDAQ:BITS) Short Interest Update - Defense World
Best Stocks Under $50 Right Now - Benzinga
Best-Performing Leveraged ETFs of Last Week - Nasdaq
ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Stock Pass Above 50-Day Moving AverageWhat's Next? - MarketBeat
Why 3x ETFs Are Riskier Than You Might Think - Investopedia
Stock Market Movers Today • Top Gainers & Losers - Benzinga
DeepSeek AI Model Sends Shockwaves Through Nvidia, Slams ETFs - Benzinga
How to Invest in SPDR S&P Biotech ETF (XBI) - The Motley Fool
4 Aggressive ETF Strategies - Investopedia
UltraShort Bitcoin ETF Offering 2x Inverse Returns Sees Record Volume as BTC Holds Above $90K - Yahoo Finance
ProShares S&P Technology Dividend Aristocrats ETF (BATS:TDV) Stock Pass Above Two Hundred Day Moving Average – Here’s Why - Defense World
Top Performing Leveraged/Inverse ETFs: 11/17/2024 - ETF Trends
Top Tech ETFs Right Now - Benzinga
Best Inverse ETFs Of 2024 - Forbes
ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Short Interest Update - MarketBeat
5 Small-cap Biotech ETFs to Watch (Updated 2024) - Investing News Network
Squarepoint Ops LLC Purchases Shares of 22,043 ProShares Ultra Russell2000 (NYSEARCA:UWM) - Defense World
Inverse ETFs: Definition and Best-Performing Examples for October 2024 - NerdWallet
5 Best Leveraged ETFs of the First Nine Months of 2024 - Yahoo Finance
Brad Jacobs' QXO Eyes $9.4 Billion Rexel Takeover - Finimize
Best ETFs for Day Trading – Updated Lists and Statistics - TradeThatSwing
Semiconductor ETFs Take A Beating, Dragged Lower By Nvidia, AMD, and Broadcom Stocks - Yahoo Finance
Nvidia ETFs Split In Pre-Market After Jensen Huang-Led Chip Giant Exceeds Q2 Expectations - Benzinga
Best 2x Leveraged ETFs - Benzinga
UVXY: The VIX Is Too Low (BATS:UVXY) - Seeking Alpha
BITU May Be Too Risky At 2x Leverage - Seeking Alpha
5 Best-Performing Leveraged ETFs of 1H - Yahoo Finance
UGL: 2x Daily Returns On Gold, But Be Careful Of Cycle (NYSEARCA:UGL) - Seeking Alpha
How To Trade Biotech Stocks: Can These Three Tips Help You Make More Profits? - Investor's Business Daily
Proshares Ultra Nasdaq Biotechnology 2 X Shares Stock (BIB) Financials Data
There is no financial data for Proshares Ultra Nasdaq Biotechnology 2 X Shares (BIB). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):